ArticleInnere Medizin (Heidelberg, Germany)2026
[Rare case of renal infarction in a patient with cor triatriatum sinistrum: clinical implications and management].
Article in Innere Medizin (Heidelberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cor triatriatum is a rare congenital cardiac anomaly with an estimated incidence among congenital heart diseases of approximately 0.1-0.4%. It is characterized by the presence of a fibromuscular membrane dividing the left atrium or right into two chambers. Approximately 83% of patients with cor triatriatum have cor triatriatum sinistrum (CTS) and 17% have cor triatriatum dextrum (CTD) [1]. CTS usually presents around 31 ± 23 years and is associated with higher rates of cardioembolic events, usually stroke due to mechanisms such as blood flow stagnation within the atrium, its association with atrial fibrillation (AF), and/or the coexistence of an atrial septal defect (ASD) or a patent foramen ovale. In contrast, CTD is associated with a significantly higher rate of cyanosis than CTS and presents earlier in life, usually around 21 ± 20 years [1]. Associated cardiac defects are common, with the most frequent being atrial septal defects (estimated incidence of 53%) and partial or total anomalous pulmonary venous drainage (estimated incidence of 27%) [2]. We describe a case highlighting the role that CTS may play in cardioembolic kidney infarction, provide high-quality cardio magnetic resonance imaging, and two- and three-dimensional echocardiography of the CTS membrane, and outline management strategies for this uncommon clinical scenario.
Indexed as
Identifiers
41081832What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.